Shang Hai Zheng Quan Bao·2025-05-26 21:35Core Viewpoint - Rongchang Biopharmaceutical (Yantai) Co., Ltd. has announced changes to its registered capital, the cancellation of its supervisory board, and revisions to its articles of association and internal management systems [1][2][3] Group 1: Changes in Registered Capital - The company completed the registration of shares from the 2022 A-share restricted stock incentive plan, resulting in an increase in total shares from 544,332,083 to 544,608,243 shares and registered capital from RMB 544,332,083 to RMB 544,608,243 [1] Group 2: Cancellation of Supervisory Board and Revisions to Articles of Association - The supervisory board will be abolished, with its powers transferred to the board's audit committee, and relevant rules will be repealed [2] - The articles of association will be revised to reflect these changes, including the removal of references to the supervisory board and adjustments to the powers of the shareholders' meeting and board of directors [3] Group 3: Revisions to Internal Management Systems - The company plans to revise several internal management systems to enhance operational compliance, with specific rules such as the shareholders' meeting rules and independent directors' work system pending approval from the shareholders' meeting [4]